Cabaletta Bio Inc at Goldman Sachs Healthcare Conference Transcript
I know. Right.
I don't know. That might have been me. Okay, I'll be in front of the speaker. Okay. I think people might be trickling in from the other sessions. No sweat. But given the timer has started, maybe we should kick it, get started.
Okay, good morning. We're happy to be hosting Cabaletta Bio. With us today we have Dr. Steven Nichtberger, CEO; Dr. Arun Das, the Chief Business Officer; and Steve Gavel, the Chief Commercial Officer. So to start, could you guys provide a high-level overview of where rese-cel stands, the overall strategy post-initiation of the pivotal myositis trial, and key catalysts we should be focusing on for the second half of '26.
Yeah. Absolutely. Thanks for the opportunity. So rese-cel was the subject of multiple data presentations recently at EULAR in London
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
